activity
20242026
collaborators

5 papers

stat.ME2026

Clustering-Based Outcome Models for Clinical Studies: A Scoping Review

Johannes Vilsmeier, Fabian Eibensteiner, Franz König +6

This review provides a systematic overview of methods that combine covariate-based clustering of observational units (patients) with outcome models for clinical studies. We disting…

stat.ML2026

Latent Neural-ODE for Model-Informed Precision Dosing: Overcoming Structural Assumptions in Pharmacokinetics

Benjamin Maurel, Agathe Guilloux, Sarah Zohar +2

Accurate estimation of tacrolimus exposure, quantified by the area under the concentration-time curve (AUC), is essential for precision dosing after renal transplantation. Current…

q-bio.QM2025

In silico clinical trials in drug development: a systematic review

Bohua Chen, Lucia Chantal Schneider, Christian Röver +15

In the context of clinical research, computational models have received increasing attention over the past decades. In this systematic review, we aimed to provide an overview of th…

stat.AP2024

Straightforward Phase I Dose-Finding Design for Healthy Volunteers Accounting for Surrogate Activity Biomarkers

Sandrine Boulet, Emmanuelle Comets, Antoine Guillon +5

Conventionally, a first-in-human phase I trial in healthy volunteers aims to confirm the safety of a drug in humans. In such situations, volunteers should not suffer from any safet…

stat.ME2024

An efficient joint model for high dimensional longitudinal and survival data via generic association features

Van Tuan Nguyen, Adeline Fermanian, Agathe Guilloux +4

This paper introduces a prognostic method called FLASH that addresses the problem of joint modelling of longitudinal data and censored durations when a large number of both longitu…